Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-type lectin domain family 6 member A protein, commonly known as Dectin‑2, is a type II transmembrane receptor belonging to the C-type lectin-like receptor family. It is primarily expressed on macrophages and dendritic cells, with lower expression in Langerhans cells and peripheral blood monocytes that can increase during inflammation. Dectin‑2 functions as a pattern recognition receptor by specifically binding α-mannans—carbohydrate structures found on the surface of many fungi—and other high mannose-containing molecules. Upon ligand binding, it initiates intracellular signaling through the CARD9-Bcl10-Malt1 pathway leading to cytokine production and activation of innate immune responses against fungal pathogens. Additionally, Dectin‑2 has been implicated in modulating allergic responses by recognizing allergens such as house dust mite components and promoting inflammatory mediator release essential for Th2-driven airway inflammation. Diseases associated with dysfunction or altered expression include various fungal infections and potentially inflammatory or allergic conditions[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-type lectin domain family 6 member A protein (Dectin-2).